CEO
Universal Brain
This company develops a data-driven platform for precision psychiatry, starting with depression treatment. They utilize a next-generation EEG wearable and the Neurotique TM ERP interface to generate objective, brain-based patient classifications called neurotypes. This neurotyping approach translates neuroscience research into functional neural measures, enabling improved patient selectivity and targeted treatment decisions for psychiatric conditions.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Medical Devices
- Software Only
Updated 7 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Problem
Current methods for diagnosing and treating depression often rely on subjective symptom reporting, leading to a one-size-fits-all approach that overlooks the underlying neurological differences between patients. This lack of precision can result in ineffective treatments and delayed recovery.
Solution
Universal Brain offers a neuroscience-based platform that uses EEG and MRI data to identify distinct neurotypes of depression, enabling more precise and personalized treatment strategies. The platform combines a next-generation EEG wearable with a digital ERP interface, providing clinicians with interpretable data about a patient's cognitive and emotional abilities. This data-driven approach supports improved diagnosis, treatment selection, and monitoring of treatment efficacy. For patients, Universal Brain provides a gamified neurofeedback system that modulates brain activity associated with depressive symptoms, offering a dynamic, engaging treatment option.
Target Audience
The primary target audience includes biopharmaceutical companies conducting clinical trials for psychiatric drugs, healthcare providers specializing in mental health, and patients seeking personalized and data-driven treatment options for depression.
Features
- Next-generation EEG wearable device for capturing real-time brain activity data
- Neurotique™ ERP app for analyzing and interpreting EEG data related to cognitive and emotional functions
- Algorithm-driven software for identifying patient-specific neurotypes based on functional brain measures
- Gamified neurofeedback system that provides real-time feedback to patients, modulating brain activity and alleviating depressive symptoms
- Clinician dashboard for accessing patient data, neurotype classifications, and treatment recommendations
- Integration of objective, brain-based measures into clinical drug trials for improved patient selection and outcome prediction